{"protocolSection":{"identificationModule":{"nctId":"NCT06053021","orgStudyIdInfo":{"id":"PERSIST"},"organization":{"fullName":"Second Affiliated Hospital, School of Medicine, Zhejiang University","class":"OTHER"},"briefTitle":"Antiplatelet Therapy for AIS Patients With Thrombocytopenia","officialTitle":"Antiplatelet Therapy for Acute Ischemic Stroke Patients With Thrombocytopenia","acronym":"PERSIST"},"statusModule":{"statusVerifiedDate":"2023-09","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-09-15","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-10-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-01-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-09-11","studyFirstSubmitQcDate":"2023-09-21","studyFirstPostDateStruct":{"date":"2023-09-25","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-10-16","lastUpdatePostDateStruct":{"date":"2023-10-18","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The goal of this clinical trial is to test the safety and effectiveness of antiplatelet therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Participants will be prescribed antiplatelet agents and followed up for 3 months.","detailedDescription":"Antiplatelet therapy is widely used in non-cardiogenic AIS patients for secondary prevention. However, it may also increase the risk of bleeding complications, especially in patients with thrombocytopenia. The goal of this clinical trial is to test the safety and effectiveness of antiplatelet therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Participants will be prescribed antiplatelet agents and followed up for 3 months."},"conditionsModule":{"conditions":["Acute Ischemic Stroke","Thrombocytopenia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":1200,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention","type":"EXPERIMENTAL","description":"Participants will be prescribed antiplatelet agents including aspirin, clopidogrel, cilostazol, and dipyridamole.","interventionNames":["Drug: aspirin, clopidogrel, cilostazol, and dipyridamole"]}],"interventions":[{"type":"DRUG","name":"aspirin, clopidogrel, cilostazol, and dipyridamole","description":"Participants will be prescribed antiplatelet agents including aspirin, clopidogrel, cilostazol, and dipyridamole.","armGroupLabels":["Intervention"],"otherNames":["Antiplatelet Agents"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"90-day Composite events","description":"Composite events including ischemic stroke, hemorrhagic stroke, myocardial infarction, major extracranial hemorrhage, and vascular death within 90 days after enrollment","timeFrame":"90 days"}],"secondaryOutcomes":[{"measure":"90-day ischemic stroke","description":"Ischemic stroke within 90 days after enrollment","timeFrame":"90 days"},{"measure":"90-day hemorrhagic stroke","description":"Hemorrhagic stroke within 90 days after enrollment","timeFrame":"90 days"},{"measure":"90-day myocardial infarction","description":"Myocardial infarction within 90 days after enrollment","timeFrame":"90 days"},{"measure":"90-day major extracranial hemorrhage","description":"Major extracranial hemorrhage within 90 days after enrollment","timeFrame":"90 days"},{"measure":"90-day non-major bleeding","description":"Non-major bleeding within 90 days after enrollment","timeFrame":"90 days"},{"measure":"90-day vascular death","description":"Vascular death within 90 days after enrollment","timeFrame":"90 days"},{"measure":"90-day all-cause death","description":"All-cause death within 90 days after enrollment","timeFrame":"90 days"},{"measure":"Discharge mRS","description":"Modified Rankin scale at discharge","timeFrame":"Through hospitalization, an average of 7 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\> 18 years old\n* Acute ischemic stroke or transient ischemic attack with onset \\< 7 days\n* The last blood routine test before enrollment indicates platelet count \\< 100 x 10\\^9 and \\> 30 x 10\\^9\n\nExclusion Criteria:\n\n* Chronic renal dysfunction (GFR \\< 30ml/min) or severe hepatic injury\n* Indications for anticoagulation therapy, e.g. atrial fibrillation\n* Myocardial infarction within 6 months before enrollment or received percutaneous coronary intervention in the past\n* Have or plan to receive CEA or CAS in the following 3 months\n* Life expectancy less than 1 year\n* Plan to receive invasive surgery in the following 3 months and have high risk of uncontrollable bleeding\n* Pregnant or lactating women\n* Individuals identified by researchers as unsuitable for participation in the study due to other reasons.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Min Lou, PhD","role":"CONTACT","phone":"+8613958007213","email":"loumingxc@vip.sina.com"}],"locations":[{"facility":"Second Affiliated Hospital, School of Medicine, Zhejiang University","status":"RECRUITING","city":"Hangzhou","country":"China","contacts":[{"name":"Min Lou, PhD","role":"CONTACT","phone":"8657187784811","email":"loumingxc@vip.sina.com"}],"geoPoint":{"lat":30.29365,"lon":120.16142}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000013921","term":"Thrombocytopenia"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001791","term":"Blood Platelet Disorders"},{"id":"D000006402","term":"Hematologic Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M16370","name":"Thrombocytopenia","asFound":"Thrombocytopenia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4762","name":"Blood Platelet Disorders","relevance":"LOW"},{"id":"M9180","name":"Hematologic Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC15","name":"Blood and Lymph Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001241","term":"Aspirin"},{"id":"D000077407","term":"Cilostazol"},{"id":"D000004176","term":"Dipyridamole"},{"id":"D000077144","term":"Clopidogrel"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"}],"ancestors":[{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000058921","term":"Purinergic P2Y Receptor Antagonists"},{"id":"D000058919","term":"Purinergic P2 Receptor Antagonists"},{"id":"D000058914","term":"Purinergic Antagonists"},{"id":"D000058905","term":"Purinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000001993","term":"Bronchodilator Agents"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000018927","term":"Anti-Asthmatic Agents"},{"id":"D000019141","term":"Respiratory System Agents"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000018696","term":"Neuroprotective Agents"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000058987","term":"Phosphodiesterase 3 Inhibitors"},{"id":"D000010726","term":"Phosphodiesterase Inhibitors"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","asFound":"Knee","relevance":"HIGH"},{"id":"M1669","name":"Clopidogrel","asFound":"Results","relevance":"HIGH"},{"id":"M1788","name":"Cilostazol","asFound":"Stored","relevance":"HIGH"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","asFound":"Antihypertensive drugs","relevance":"HIGH"},{"id":"M7048","name":"Dipyridamole","asFound":"Relaxing","relevance":"HIGH"},{"id":"M3907","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M3908","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M20476","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M20294","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M18899","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M28866","name":"Antipyretics","relevance":"LOW"},{"id":"M28984","name":"Purinergic P2Y Receptor Antagonists","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"},{"id":"M4959","name":"Bronchodilator Agents","relevance":"LOW"},{"id":"M20653","name":"Anti-Asthmatic Agents","relevance":"LOW"},{"id":"M20827","name":"Respiratory System Agents","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M20463","name":"Neuroprotective Agents","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"M29023","name":"Phosphodiesterase 3 Inhibitors","relevance":"LOW"},{"id":"M13319","name":"Phosphodiesterase Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"NeuroAg","name":"Neuroprotective Agents"},{"abbrev":"Resp","name":"Respiratory System Agents"}]}},"hasResults":false}